Home › Diabetes › North Carolina › Raleigh
Diabetes clinical trials in Raleigh, NC
4 studies for Diabetes are looking for participants at sites in and around Raleigh (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
RecruitingPhase 2/3
- North Carolina Nephrology, PA, Raleigh
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
RecruitingPhase 1/2
- Wake Research - Raleigh, Raleigh
- Superior Clinical Research, Smithfield · 25 mi away
Assessment of AI Program 'DRISTi' as a Screening Tool
RecruitingObservational studyHealthy volunteers welcome
- New Century Ophthalmology - Raleigh, Raleigh
Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers
Recruiting
- Foot and Ankle Specialists of the Mid-Atlantic, Raleigh
About Diabetes
Diabetes is a chronic health condition in which your blood glucose levels are too high. There is no cure, but diet, exercise, medications, and weight control can help.
More about Diabetes on MedlinePlus
Diabetes trials in other cities
- Boston, MA23 studies
- New York City, NY17 studies
- Houston, TX16 studies
- Chicago, IL15 studies
- Durham, NC14 studies
- Aurora, CO14 studies
- Baltimore, MD13 studies
- Philadelphia, PA12 studies
- San Diego, CA10 studies
- Los Angeles, CA10 studies
- Indianapolis, IN10 studies
- Washington, DC10 studies
Other studies in Raleigh
- Heart Failure7 studies
- Coronary Artery Disease6 studies
- Obesity6 studies
- Type 2 Diabetes6 studies
- Macular Degeneration6 studies
- Atherosclerosis5 studies
- Overweight5 studies
- Cardiovascular Disease5 studies
- Endometrial Cancer5 studies
- Stroke5 studies
- Kidney Failure4 studies
- Ovarian Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.